CRTPF News and Press, Cardiol Therapeutics From 10/01/19

Oakville, Ontario--(Newsfile Corp. - October 1, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) (OTCQX: CRTPF ) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical CBD products and in the development of innovative CBD medicines for heart disease, announces that it has com...

/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/ /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/ Canada NewsWire NEW YORK, Sept. 6, 2019 Cannabis Com...

NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to atten...

Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th Canada NewsWire NEW YORK, Sept. 6, 2019 Cannabis Company Executives share vision, answer ...

Oakville, Ontario--(Newsfile Corp. - September 5, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) (OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in producing the purest pharmaceutical CBD products and developing innovative therapies for heart disease, today announced that David Elsl...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

Oakville, Ontario--(Newsfile Corp. - July 25, 2019) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (" Cardiol " or the " Company "), focused on producing pharmaceutical CBD products and developing innovative therapies for heart disease, including acute myocarditis and other causes of h...

NEW YORK , July 3, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Grit Capital, today announced that the presentations from our recent virtual event are now available for on-demand viewing. Eight public & private company executives provided insight on inno...

The following slide deck was published by Cardiol Therapeutics Inc. in conjunction with this Read more ...